Arcutis Officer Files Intent to Sell $91K in Stock (ARQT)
Arcutis Biotherapeutics, Inc.
Subscribe to track ARQT
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Arcutis Officer Files Intent to Sell $91K in Stock (ARQT)
Company: Arcutis Biotherapeutics, Inc. (ARQT) Form: 144 | Filed: 2025-11-05 Significance: Low
Insider: Patrick Burnett Title: Officer
Transaction: • Type: Proposed Sale • Shares: 3,846 • Value: $91,216 • Price: ~$23.72/share
Key Insight: This is a minor, pre-planned sale by an officer, representing a negligible fraction (0.0031%) of the company's $2.94B market cap. The sale is pursuant to a 10b5-1 trading plan adopted in December 2024.
Market Context: The small size and pre-scheduled nature of the sale suggest it is for personal financial management and is unlikely to have a material impact on the stock.
Comprehensive Analysis
SEC Filing Analysis: Arcutis Biotherapeutics, Inc. (ARQT)
Executive Summary
- Trading Significance: Low
- Key Takeaway: An officer of Arcutis Biotherapeutics has filed a notice of proposed sale for 3,846 shares, valued at approximately $91,216. The transaction is pre-planned under a Rule 10b5-1 plan.
- Market Impact: Neutral. The transaction size is immaterial relative to the company's market capitalization and public float.
Company Information
| Field | Value |
|---|---|
| Company | Arcutis Biotherapeutics, Inc. |
| Ticker Symbol | ARQT |
| CIK | 0001787306 |
| Industry | Pharmaceutical Preparations |
Insider Information
| Field | Value |
|---|---|
| Name | Patrick Burnett |
| CIK | 0001741987 |
| Title/Position | Officer |
| Relationship | Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 144 |
| Transaction Date | 2025-11-05 (Approximate) |
| Transaction Code | N/A (Proposed Sale) |
| Security Type | Common Stock |
| Shares Involved | 3,846 |
| Price Per Share | ~$23.72 (Calculated) |
| Total Value | $91,216 |
| Shares Owned After | Not specified |
| Ownership Type | Not specified |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $91,216 |
| % of Market Cap | 0.0031% |
| Shares Transacted | 3,846 |
| % of Shares Outstanding | 0.0032% |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: For a company with a market capitalization of $2.94 billion, this $91,216 transaction is de minimis and represents routine financial activity for an executive.
- Transaction Significance: The sale constitutes a negligible percentage of both market cap and shares outstanding, falling far below the thresholds for moderate or high significance.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The sale is extremely small and was pre-scheduled via a 10b5-1 plan. This removes any implication that the sale is based on new non-public information, resulting in a neutral market sentiment.
Volume & Sentiment
- Expected Volume Impact: Negligible. The transaction size is too small to noticeably affect daily trading volume.
- Sentiment Indicator: Neutral. This is a routine, non-eventful filing.
Additional Context
Special Circumstances
- The filing indicates the proposed sale is pursuant to a Rule 10b5-1 trading plan adopted on December 12, 2024. This confirms the sale was planned in advance.
- The filing also discloses several other small sales by the same insider in the preceding three months, establishing a pattern of regular, small-scale dispositions.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.